Literature DB >> 16123023

Microcracks colocalize within highly mineralized regions of cortical bone tissue.

Nicholas Wasserman1, Janardhan Yerramshetty, Ozan Akkus.   

Abstract

While much work has been performed to quantify the extent of bone damage, its effects on the mechanical integrity of the tissue and its biological impact, the set of factors which gives forth to microdamage are nebulous, particularly the compositional properties local to microdamage. In this context, the current study tested the hypothesis that microcracks initiate within more mineralized regions of bone. Cortical bone specimens were taken from human male donors aged 31, 38, 53, 64, 71, and 84 years at the mid femoral diaphysis in a plane parallel to the osteonal orientation. The mineralization was assessed in a spatially resolved manner using Raman microspectroscopy. Arrays of measurements were taken over the entire area (i.e. global scans) of each sample followed by measurements in the vicinity of microcracks (i.e. local scans). Histograms of mineralization were constructed for global and local scans to determine whether the mineralization of damaged loci differed from the mean overall mineralization. Statistical analysis of this data revealed that the mean mineralization of damaged loci was significantly greater (P < 0.05) than the overall mineralization for each donor, indicating that there exists a highly-mineralized 'brittle volume' in bone. The presence of this damage prone 'brittle volume' has future implications for the assessment of fracture susceptibility.

Entities:  

Mesh:

Year:  2005        PMID: 16123023     DOI: 10.1080/09243860500095471

Source DB:  PubMed          Journal:  Eur J Morphol        ISSN: 0924-3860


  13 in total

Review 1.  Subtrochanteric femoral insufficiency fractures related to the use of long-term bisphosphonates: a pictorial review.

Authors:  Nanda Venkatanarasimha; Gemma Miles; Priya Suresh
Journal:  Emerg Radiol       Date:  2010-07-20

Review 2.  Is bone quality associated with collagen age?

Authors:  D J Leeming; K Henriksen; I Byrjalsen; P Qvist; S H Madsen; P Garnero; M A Karsdal
Journal:  Osteoporos Int       Date:  2009-03-28       Impact factor: 4.507

3.  Effects of trabecular type and orientation on microdamage susceptibility in trabecular bone.

Authors:  Xiutao Shi; X Sherry Liu; Xiang Wang; X Edward Guo; Glen L Niebur
Journal:  Bone       Date:  2010-02-10       Impact factor: 4.398

4.  Atypical femoral diaphyseal and subtrochanteric fractures and their association with bisphosphonates.

Authors:  Frankie Leung; Tak-Wing Lau; Michael To; Keith Dip-Kei Luk; Annie Wai Chee Kung
Journal:  BMJ Case Rep       Date:  2009-03-05

5.  Bilateral Femoral Neck Insufficiency Fractures after Use of a Long-term Anti-resorptive Drug Therapy for Osteoporosis: A Case Report.

Authors:  Dong-Ki Ahn; Jin-Hak Kim; Jae-Il Lee; Jin-Woo Kim
Journal:  Hip Pelvis       Date:  2015-06-30

6.  Morphology, localization and accumulation of in vivo microdamage in human cortical bone.

Authors:  Tamim Diab; Deepak Vashishth
Journal:  Bone       Date:  2006-11-13       Impact factor: 4.398

7.  Exercise-induced metacarpophalangeal joint adaptation in the Thoroughbred racehorse.

Authors:  P Muir; A L Peterson; S J Sample; M C Scollay; M D Markel; V L Kalscheur
Journal:  J Anat       Date:  2008-12       Impact factor: 2.610

8.  How tough is brittle bone? Investigating osteogenesis imperfecta in mouse bone.

Authors:  R O Ritchie; S J Shefelbine; A Carriero; E A Zimmermann; A Paluszny; S Y Tang; H Bale; B Busse; T Alliston; G Kazakia
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

Review 9.  Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses.

Authors:  Eric Lespessailles; Ridha Hambli; Serge Ferrari
Journal:  Bonekey Rep       Date:  2016-08-31

10.  A quasi-brittle continuum damage finite element model of the human proximal femur based on element deletion.

Authors:  Ridha Hambli
Journal:  Med Biol Eng Comput       Date:  2012-11-21       Impact factor: 2.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.